Welcome to our dedicated page for Plandai Biotechnology news (Ticker: PLPL), a resource for investors and traders seeking the latest updates and insights on Plandai Biotechnology stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Plandai Biotechnology's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Plandai Biotechnology's position in the market.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Plandai Biotechnology, Inc. (OTC PINK:PLPL) has announced a binding memorandum of understanding to acquire Good Salt, LLC, which includes the assets and operations of ByoPlanet International and Clean Republic. ByoPlanet specializes in electrostatic cleaning technology that improves disinfection efficiency and reduces chemical usage. This acquisition aligns with Plandai's new strategic direction, focusing on health technology innovation. Additionally, Plandai is preparing for a potential up listing, having completed audits for its fiscal years ending June 30, 2022, and June 30, 2021. The company plans to change its name to ByoPlanet, Inc. and seek a new trading symbol, pending regulatory approval.
Plandai Biotechnology, Inc. (OTC: PLPL) has terminated its asset acquisition agreement with EV Hotel Corp. without incurring any penalties. This decision was mutually agreed upon by both parties. Additionally, the Company has completed a two-year independent audit of its financial statements, which will inform future disclosures and ongoing merger efforts. Plandai seeks to generate shareholder value by merging with entities offering growth opportunities.
FAQ
What is the current stock price of Plandai Biotechnology (PLPL)?
What is the market cap of Plandai Biotechnology (PLPL)?
